Susquehanna International Group
PTCT icon

Susquehanna International Group’s PTC Therapeutics PTCT Stock Holding History

Susquehanna International Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.66M Sell
83,100
-45,600
-35% -$3.23M ﹤0.01% 4020
2025
Q4 		$9.78M Buy
128,700
+4,200
+3% +$305K ﹤0.01% 3072
2025
Q3 		$7.64M Buy
124,500
+56,200
+82% +$2.93M ﹤0.01% 3408
2025
Q2 		$3.34M Sell
68,300
-43,900
-39% -$2.08M ﹤0.01% 4748
2025
Q1 		$5.72M Sell
112,200
-96,000
-46% -$4.79M ﹤0.01% 3402
2024
Q4 		$9.4M Buy
208,200
+200,700
+2,676% +$8.59M ﹤0.01% 2737
2024
Q3 		$278K Sell
7,500
-66,000
-90% -$2.21M ﹤0.01% 9771
2024
Q2 		$2.25M Buy
73,500
+38,300
+109% +$1.24M ﹤0.01% 4871
2024
Q1 		$1.02M Buy
35,200
+20,000
+132% +$560K ﹤0.01% 6853
2023
Q4 		$419K Buy
15,200
+1,000
+7% +$22.9K ﹤0.01% 9086
2023
Q3 		$318K Sell
14,200
-8,800
-38% -$327K ﹤0.01% 9220
2023
Q2 		$935K Buy
23,000
+14,600
+174% +$714K ﹤0.01% 6844
2023
Q1 		$407K Sell
8,400
-46,200
-85% -$2.11M ﹤0.01% 9061
2022
Q4 		$2.08M Buy
54,600
+14,500
+36% +$603K ﹤0.01% 4623
2022
Q3 		$2.01M Buy
40,100
+28,300
+240% +$1.39M ﹤0.01% 4916
2022
Q2 		$473K Sell
11,800
-17,400
-60% -$610K ﹤0.01% 8405
2022
Q1 		$1.09M Buy
29,200
+16,800
+135% +$647K ﹤0.01% 6890
2021
Q4 		$494K Sell
12,400
-39,100
-76% -$1.5M ﹤0.01% 9252
2021
Q3 		$1.92M Buy
51,500
+44,400
+625% +$1.82M ﹤0.01% 5932
2021
Q2 		$300K Buy
7,100
+1,900
+37% +$81.4K ﹤0.01% 10771
2021
Q1 		$246K Buy
+5,200
New +$309K ﹤0.01% 11018
2020
Q4 		– Sell
-29,700
Closed -$1.39M – 11589
2020
Q3 		$1.39M Sell
29,700
-62,200
-68% -$3.06M ﹤0.01% 5340
2020
Q2 		$4.66M Sell
91,900
-48,200
-34% -$2.37M ﹤0.01% 3099
2020
Q1 		$6.25M Sell
140,100
-115,000
-45% -$5.79M ﹤0.01% 2294
2019
Q4 		$12.3M Buy
255,100
+33,600
+15% +$1.43M ﹤0.01% 1872
2019
Q3 		$7.49M Buy
221,500
+154,700
+232% +$6.73M ﹤0.01% 2272
2019
Q2 		$3.01M Buy
66,800
+42,300
+173% +$1.67M ﹤0.01% 3446
2019
Q1 		$922K Sell
24,500
-25,900
-51% -$870K ﹤0.01% 5201
2018
Q4 		$1.73M Sell
50,400
-68,600
-58% -$2.47M ﹤0.01% 3737
2018
Q3 		$5.59M Sell
119,000
-83,500
-41% -$3.46M ﹤0.01% 2545
2018
Q2 		$6.83M Sell
202,500
-60,800
-23% -$1.9M ﹤0.01% 2360
2018
Q1 		$7.13M Sell
263,300
-261,100
-50% -$6.62M ﹤0.01% 2128
2017
Q4 		$8.75M Sell
524,400
-862,700
-62% -$14.6M ﹤0.01% 1939
2017
Q3 		$27.8M Buy
1,387,100
+1,170,600
+541% +$22.9M 0.01% 1001
2017
Q2 		$3.97M Buy
216,500
+2,900
+1% +$39.1K ﹤0.01% 2715
2017
Q1 		$2.1M Sell
213,600
-168,000
-44% -$2.03M ﹤0.01% 3640
2016
Q4 		$4.16M Buy
381,600
+207,700
+119% +$2.18M ﹤0.01% 2729
2016
Q3 		$2.44M Buy
173,900
+17,500
+11% +$142K ﹤0.01% 3235
2016
Q2 		$1.1M Sell
156,400
-20,000
-11% -$147K ﹤0.01% 4693
2016
Q1 		$1.14M Sell
176,400
-186,300
-51% -$3.23M ﹤0.01% 4825
2015
Q4 		$11.8M Sell
362,700
-44,000
-11% -$1.3M 0.01% 1608
2015
Q3 		$10.9M Buy
406,700
+54,000
+15% +$2.31M ﹤0.01% 1749
2015
Q2 		$17M Buy
352,700
+31,900
+10% +$1.86M 0.01% 1463
2015
Q1 		$19.5M Buy
320,800
+288,800
+903% +$17.6M 0.01% 1259
2014
Q4 		$1.66M Buy
+32,000
New +$1.41M ﹤0.01% 4813

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Susquehanna International Group's PTCT Position: Q1 2026 in Review

Susquehanna International Group increased its PTC Therapeutics (PTCT) stake by 1,013% in Q1 2026, buying an estimated $13.4M and bringing the position to 207,938 shares worth $14.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2633.

Susquehanna International Group first reported a position in PTCT in Q1 2014 and has held it in 40 quarters since. The position peaked at $21.1M in Q2 2025. 351 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Susquehanna International Group held 207,938 shares of PTC Therapeutics worth $14.2M as of Q1 2026.
  • Susquehanna International Group bought 189,257 PTC Therapeutics shares in Q1 2026, an estimated $13.4M.
  • PTC Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2633 holding.
  • Susquehanna International Group first reported a position in PTC Therapeutics in Q1 2014 and has held it in 40 quarters since.
  • Susquehanna International Group's PTC Therapeutics position peaked at $21.1M in Q2 2025.
  • 351 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.